We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO: FDA Meeting Performance Goals While Review Times Grow Longer
GAO: FDA Meeting Performance Goals While Review Times Grow Longer
May 4, 2012
The FDA generally met its performance goals for both priority and standard NDAs and BLAs between fiscal 2000 and 2010, but the time it took the agency to review those applications has slightly increased, according to a new Government Accountability Office (GAO) report.